Rehan Khan - Publications

Affiliations: 
Mayo Clinic, Rochester, MN, United States 
Area:
CXCR4 Signaling

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Sharma M, Khan R, Aggarwal M, Sharma A. Modulatory Effects of Chemoradiation on Angiogenic Factors and Laminin in Cervical Cancer: Link with Treatment Response Asian Pacific Journal of Cancer Prevention : Apjcp. 18: 2937-2944. PMID 29172262 DOI: 10.22034/Apjcp.2017.18.11.2937  0.34
2017 Kumar R, Khan R, Gupta N, Seth T, Sharma A, Kalaivani M, Sharma A. Identifying the biomarker potential of telomerase activity and shelterin complex molecule, telomeric repeat binding factor 2 (TERF2), in multiple myeloma. Leukemia & Lymphoma. 1-13. PMID 29043869 DOI: 10.1080/10428194.2017.1387915  0.324
2015 Gupta N, Khan R, Kumar R, Kumar L, Sharma A. Versican and its associated molecules: potential diagnostic markers for multiple myeloma. Clinica Chimica Acta; International Journal of Clinical Chemistry. 442: 119-24. PMID 25623955 DOI: 10.1016/J.Cca.2015.01.012  0.32
2014 Khan R, Gupta N, Kumar R, Sharma M, Kumar L, Sharma A. Augmented expression of urokinase plasminogen activator and extracellular matrix proteins associates with multiple myeloma progression. Clinical & Experimental Metastasis. 31: 585-93. PMID 24807734 DOI: 10.1007/S10585-014-9652-7  0.33
2013 Khan R, Sharma M, Kumar L, Husain SA, Sharma A. Interrelationship and expression profiling of cyclooxygenase and angiogenic factors in Indian patients with multiple myeloma. Annals of Hematology. 92: 101-9. PMID 22971811 DOI: 10.1007/S00277-012-1572-5  0.329
2012 Bhagirath D, Abrol N, Khan R, Sharma M, Seth A, Sharma A. Expression of CD147, BIGH3 and Stathmin and their potential role as diagnostic marker in patients with urothelial carcinoma of the bladder. Clinica Chimica Acta; International Journal of Clinical Chemistry. 413: 1641-6. PMID 22626996 DOI: 10.1016/J.Cca.2012.05.005  0.317
2012 Khan R, Sharma M, Sharma A. Abstract 5184: Expression profiling of ECM proteins in advanced carcinoma of uterine cervix Cancer Research. 72: 5184-5184. DOI: 10.1158/1538-7445.Am2012-5184  0.33
2012 Sharma A, Khan R, Sharma M, Kumar L. 37 Expression Profiling of Angiogenic Factors, ECM Proteins and Inflammatory Markers and Their Correlation in Indian Patients with Multiple Myeloma European Journal of Cancer. 48: 14. DOI: 10.1016/S0959-8049(12)71836-1  0.314
2011 Joshi S, Khan R, Sharma M, Kumar L, Sharma A. Angiopoietin-2: a potential novel diagnostic marker in multiple myeloma. Clinical Biochemistry. 44: 590-5. PMID 21300047 DOI: 10.1016/J.Clinbiochem.2011.01.010  0.336
2010 Sharma A, Khan R, Joshi S, Sharma M, Kumar L. Abstract B43: Role of angiogenic factors and extracellular matrix proteins in multiple myeloma Cancer Prevention Research. 3. DOI: 10.1158/1940-6207.Prev-09-B43  0.337
2010 Sharma M, Sharma A, Khan R. Abstract A43: Effect of chemoradiation on oxidant‐antioxidant profile and its correlation with therapeutic response in patients with carcinoma of posterior one third of tongue Cancer Prevention Research. 3. DOI: 10.1158/1940-6207.Prev-09-A43  0.318
Show low-probability matches.